Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments ...

The UCLA advance opens the door to growing other vascularized organ models, including intestines and colons, providing ...

A team of researchers from APL and the Johns Hopkins Bloomberg School of Public Health is developing next-generation brain organoid platforms to better understand the effects of mild blast-induced ...

Emiri Nakamura and Professor Koji Eto (Department of Clinical Application) has identified microtubule (MT) destabilization as ...

Organ-on-a-chip systems offer a more accurate, ethical, and scalable alternative to animal testing in drug discovery and ...

Researchers from the Universidade do Porto have identified promising anti-cancer properties in four lesser-known cannabinoids ...

The initiative was announced last year and will pay up to $19,000 for one round of IVF for patients between the ages of 18 ...

Researchers at ETH Zurich are developing a model in the lab made from human breast milk cells. They hope it will help them ...

Drs Olga Brieieva and Martin Higgs discuss in vitro genomic models for predicting clinical resistance to PARP inhibitors for ...

A summary of preclinical evaluation methods for neuroendovascular devices, including in vitro techniques, 3D-printed vascular models, in silico simulations, and in vivo models.

Although these in vitro models will also not substitute totally for their in vivo counterparts, the benefits over non-human models are clear. The FDA Modernization Act 2.0 and the proposed FDA ...

In vitro models have significantly advanced cancer research and drug discovery by enabling a deeper understanding of human biology. The most common in vitro assays use two-dimensional (2D) cell ...